Risarestat is an experimental aldose reductase inhibitor that has been investigated as a potential treatment for diabetic complications, particularly diabetic polyneuropathy. The development of risarestat has faced significant challenges, and it is not currently approved for clinical use as a drug. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Risarestat [INN] and risarestatum. Its PubChem CID is 133264.
Risarestat
| CAS No | 79714-31-1 |
|---|---|
| Molecular Formula | C16H21NO4S |
| Molecular Weight | 323.4 g/mol |
| Synonyms | 5-(3-ethoxy-4-pentoxyphenyl)-1,3-thiazolidine-2,4-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Risarestat is an experimental aldose reductase inhibitor that has been investigated as a potential treatment for diabetic complications, particularly diabetic polyneuropathy.
The listed CAS number is 79714-31-1.
The listed molecular formula is C16H21NO4S.
The listed molecular weight is 323.4 g/mol.
5-(3-ethoxy-4-pentoxyphenyl)-1,3-thiazolidine-2,4-dione.
The source lists Risarestat [INN] and risarestatum.